logo-loader
Minds + Machines Group Limited

Minds + Machines inks agreement to integrate Ethereum blockchain into domain extension

The agreement with the Ethereum Name Service will allow registrants on its domain to link their domain address with a 40 character hash identifier used on the Ethereum blockchain

Ethereum symbol
The firm is hoping the agreement will broaden the market of Ethereum users

Minds + Machines Group Limited (LON:MMX) has entered into an exclusive agreement to integrate the Ethereum blockchain into its upcoming top-level domain name ‘.luxe’.

The internet domain commercialisation group said the agreement with Ethereum’s Ethereum Name Service (ENS) would allow registrants on its domain to link their domain address with a 40 character hash identifier used on the Ethereum blockchain to denote an asset, item or service supporting Ethereum.

WATCH: Minds + Machines to integrate Ethereum blockchain into domain extension

The company added that it believed the opportunities for this service were “significant” and could help broaden the market with “easy-to-remember blockchain enabled .luxe names” as opposed to the 40 character identifiers currently used.

Toby Hall, chief executive of Minds + Machines, said there was already “a real proven demand for word-based identifiers that are blockchain enabled”, adding that the ENS had already received deposits of over US$28mln on around 300,000 seven character words and above on its ‘.eth’ domain.

The group also said the ‘.luxe’ extension would also allow names to resolve over the internet in the normal way for email or web-based traffic, complementing ‘.luxe’ addresses used for traditional internet activity with those that are used for Ethereum related items or services.

The ‘.luxe’ extension is set to enter pre-launch phases shortly before going on sale to the public from 30 October 2018.

Quick facts: Minds + Machines Group Limited

Price: £0.06

Market: AIM
Market Cap: £51.97 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Minds + Machines Group Limited named herein, including the promotion by the Company of Minds + Machines Group Limited in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Shield Therapeutics targets $1bn US market after FDA...

Top stories from the Proactive Investors UK newsroom. Shield Therapeutics (LON:STX) has been given approval by the US Food and Drug Administration to sell its lead product Feraccru as a treatment for iron deficiency in adults. The US prescription market for iron replacement therapy is...

on 26/7/19

2 min read